Acacia (ACHC) - Get Acadia Healthcare Company, Inc. Report was downgraded to neutral from overweight at Cantor Fitzgerald. $45 price target. Earnings estimates were also cut, as acquisitions are being pushed out, Cantor said.
Ford (F) - Get Ford Motor Company Report was upgraded to outperform at RBC Capital. $14 price target. The valuation is more attractive, as the stock has lagged GM by 21% since last September, RBC said.
Neurocrine Bio (NBIX) - Get Neurocrine Biosciences, Inc. Report was upgraded to outperform at Oppenheimer. $55 price target. The valuation is more attractive, as the stock is down 22% over the past two months, Oppenheimer said.
Primoris (PRIM) - Get Primoris Services Corporation Report was upgraded to buy from hold at Canaccord Genuity. $28 price target. The company has better visibility for growth and margins, Canaccord said.
Praxair (PX) was upgraded to overweight from neutral at JPMorgan. $125 price target. The company stands to benefit from increased U.S. industrial activity, JPMorgan said.
This article was written by a staff member of TheStreet.